"Designing Growth Strategies is in our DNA"

Short Bowel Syndrome Market Size, Share & Industry Analysis, By Type (GLP-2, Growth Hormone, and Glutamine), By Distribution Channel (Hospital Pharmacies and Online & Retail Pharmacies), and Regional Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107071

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 7.9% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Type

  • GLP-2
  • Growth Hormone
  • Glutamine

By Distribution Channel

  • Hospital Pharmacies
  • Online & Retail Pharmacies

By Region

  • North America (By Type, By Distribution Channel, By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Distribution Channel, By Country/Sub-Region)
    • Germany
    • U.K
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Type, By Distribution Channel, By Country/Sub-Region)
    • India
    • China
    • Japan
    • Australia
    • Southeast Asia
    • South Korea
    • Rest of Asia Pacific
  • Latin America (By Type, By Distribution Channel, By Country/Sub-Region)
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of Latin America
  • Middle East & Africa (By Type, By Distribution Channel, By Country/Sub-Region)
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of the Middle East & Africa
  • 2019-2032
  • 2023
  • 2019-2022
  • 127
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann